Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides
M. N. Fukuda, M. Nonaka, H. Mabashi-Asazuma, D. L. Jarvis, K. Yamasaki, T. Akama, M. Nagaoka, T. Sasai, I. Kimura-Takagi, Y. Suwa, T. Yaegashi, C.-T. Huang, C. Nishizawa-Harada
The paper develops an orally-administrable therapeutic using annexin A1-binding D-peptides to target tumor vasculature, showing suppression of brain tumor growth in mice.
PLOS ONE · Jan 6, 2021Peer-reviewedPharmacology & Toxicology